Searched for
SUN PHARMA ADVANCED RESEARCH SHARE PRICE
Capricorn Weekly Horoscope (15th June - 21st June 2026): Partnerships and Persistence Become Your Greatest StrengthsCapricorn Weekly Horoscope (15th June 2026 to 21st June 2026): This weekly horoscope indicates a transformative week. The Moon will transit...- Falling crude oil price sends tyre, paint, oil marketing and airline companies soaring in relief rallyOn Friday, a significant drop in oil prices caused a ripple effect in the stock market, with companies linked to crude oil benefiting the m...
- Peaccemeal cheers bulls as Dalal Street logs biggest gains in over 2 monthsIn a remarkable turnaround, Indian stock markets soared on Friday, with major indices climbing over two percent, their highest gains in the...
- US stocks end higher as SpaceX shares surge in market debutIndian markets saw a positive close on Friday. Hopes for a peace deal between Iran and the United States boosted investor sentiment. SpaceX...
- India sends measles vaccines, medical supplies to Maldives amid rising casesIndia has provided 20,000 measles vaccine doses and three tonnes of medical supplies to the Maldives. This assistance aims to address incre...
- Sun Transit in Gemini June 2026: Communication, Opportunities & Fast-Paced Growth for Every Zodiac SignThe Sun transit in Gemini on June 15, 2026 brings a noticeable shift toward communication, networking, learning, adaptability, and new oppo...
- Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...
- Market Trading Guide: Allied Blenders among 2 stock recommendations for FridayDomestic markets recovered modestly on easing oil prices and selective buying in banking and pharma stocks. Analysts have recommended Allie...
- Not LPG, but sunlight is helping restaurant in Odisha cook and serve piping hot biryani even after sun goes downAn Odisha cafe is revolutionizing biryani preparation with a 100% solar-powered kitchen, even operating after sunset and on cloudy days. De...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Charting 6G Road Map: Talks soon with focus on desi tech and patentsIndia is initiating plans for a 6G mobile communication transition. Discussions will focus on developing local technology and fostering res...
- Market Trading Guide: Akums Drugs among 4 stock recommendations for ThursdayDomestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain ...
- India's current account deficit to remain 1.5-1.7% of GDP in FY27 but RBI measures may turn BoP surplus: SBI ReportIndia's current account deficit is projected for FY27. However, Reserve Bank of India measures are anticipated to improve the country's ext...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- What is Planet Nine, and where is it? Mystery of large hidden planet beyond Neptune explainedWhat is Planet Nine, and where is it? The question has fascinated astronomers for years. Scientists believe a massive undiscovered planet m...
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendSun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...
Load More
